12:00 AM
 | 
Dec 20, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Avdesp: Phase III start

Next quarter, Avesthagen will begin a double-blind, active-controlled, Indian Phase III trial of Avdesp.

Avesthagen Ltd., Bangalore, India
Product: Avdesp
Business: Hematology
Molecular...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >